Grandis JR - Search Results

1

Dual kinase inhibition of EGFR and HER2 overcomes resistance to cetuximab in a novel in vivo model of acquired cetuximab resistance.

Quesnelle KM, Grandis JR. Quesnelle KM, et al. Among authors: grandis jr. Clin Cancer Res. 2011 Sep 15;17(18):5935-44. doi: 10.1158/1078-0432.CCR-11-0370. Epub 2011 Jul 26. Clin Cancer Res. 2011. PMID: 21791633 Free PMC article.

2

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

Grandis JR, Tweardy DJ. Grandis JR, et al. Cancer Res. 1993 Aug 1;53(15):3579-84. Cancer Res. 1993. PMID: 8339264

3

Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.

Drenning SD, Marcovitch AJ, Johnson DE, Melhem MF, Tweardy DJ, Grandis JR. Drenning SD, et al. Among authors: grandis jr. Clin Cancer Res. 1998 Nov;4(11):2913-21. Clin Cancer Res. 1998. PMID: 9829760

4

Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.

Zeng Q, Smith DC, Suscovich TJ, Gooding WE, Trump DL, Grandis JR. Zeng Q, et al. Among authors: grandis jr. Clin Cancer Res. 2000 Jun;6(6):2245-51. Clin Cancer Res. 2000. PMID: 10873074 Clinical Trial.

5

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.

Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA. Grandis JR, et al. Clin Cancer Res. 2000 Jul;6(7):2794-802. Clin Cancer Res. 2000. PMID: 10914726

6

Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.

Lango MN, Shin DM, Grandis JR. Lango MN, et al. Among authors: grandis jr. Curr Opin Oncol. 2001 May;13(3):168-75. doi: 10.1097/00001622-200105000-00007. Curr Opin Oncol. 2001. PMID: 11307060 Review.

7

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR. Song JI, et al. Among authors: grandis jr. Cancer Res. 2001 Aug 1;61(15):5919-25. Cancer Res. 2001. PMID: 11479234

8

Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy.

Li M, Ye C, Feng C, Riedel F, Liu X, Zeng Q, Grandis JR. Li M, et al. Among authors: grandis jr. Clin Cancer Res. 2002 Nov;8(11):3570-8. Clin Cancer Res. 2002. PMID: 12429648

9

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, Kassis J, Drenning SD, Grandis JR. Thomas SM, et al. Among authors: grandis jr. Cancer Res. 2003 Sep 1;63(17):5629-35. Cancer Res. 2003. PMID: 14500405

10

Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells.

Lango M, Wentzel AL, Song JI, Xi S, Johnson DE, Lamph WW, Miller L, Grandis JR. Lango M, et al. Among authors: grandis jr. Clin Cancer Res. 2003 Sep 15;9(11):4205-13. Clin Cancer Res. 2003. PMID: 14519647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters